menu
    • menu

    Company profile for Citius Oncology

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Citius Oncology is a biotechnology company dedicated to developing innovative cancer therapies designed to enhance patient care and outcomes. We focus on discovering and advancing next-generation oncology treatments that address unmet medical needs. By leveraging cutting-edge research and technology, Citius Oncology aims to deliver safe, effective, and targeted solutions to combat various types of cancer. Our mission is to tra...
    Citius Oncology is a biotechnology company dedicated to developing innovative cancer therapies designed to enhance patient care and outcomes. We focus on discovering and advancing next-generation oncology treatments that address unmet medical needs. By leveraging cutting-edge research and technology, Citius Oncology aims to deliver safe, effective, and targeted solutions to combat various types of cancer. Our mission is to transform cancer treatment and improve the lives of patients worldwide through innovative science and a commitment to excellence.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Citius OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11 Commerce Drive, First Floor Cranford, NJ 07016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.citiusonc.com/overview/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Citius Pharma Reveals Fy2025 Financials And Business Update
    Citius Pharma Reveals Fy2025 Financials And Business Update

    24 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-302648899.html

    PR NEWSWIRE
    24 Dec 2025
    Share Share
    Citius Oncology Reports Fy2025 Results & Business Update
    Citius Oncology Reports Fy2025 Results & Business Update

    24 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-302648892.html

    PR NEWSWIRE
    24 Dec 2025
    Share Share
    Citius Oncology Closes $18M Offering Under Nasdaq Rules
    Citius Oncology Closes $18M Offering Under Nasdaq Rules

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-announces-closing-of-18-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-302638505.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Citius Oncology Announces $18M Direct Offering and Private
    Citius Oncology Announces $18M Direct Offering and Private

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-announces-18-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules-302636297.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Citius Oncology Expands LYMPHIR Distribution To Turkey
    Citius Oncology Expands LYMPHIR Distribution To Turkey

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-expands-lymphir-distribution-to-turkey-and-middle-east-countries-through-exclusive-agreement-with-er-kim-302632064.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Citius Oncology Launches LYMPHIR for CTCL in U.S
    Citius Oncology Launches LYMPHIR for CTCL in U.S

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citius-oncology-announces-us-commercial-launch-of-lymphir-a-novel-cancer-immunotherapy-for-cutaneous-t-cell-lymphoma-ctcl-302627320.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search